Notable LabsNTBL
Market Cap: $4.62M
About: Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.
Employees: 16
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
100% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
21% more funds holding
Funds holding: 14 [Q1] → 17 (+3) [Q2]
0.4% more ownership
Funds ownership: 4.04% [Q1] → 4.44% (+0.4%) [Q2]
58% less capital invested
Capital invested by funds: $646K [Q1] → $270K (-$376K) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for NTBL.